The trademark application was filed by Mitsubishi Tanabe Pharma Corporation, a corporation established under the laws of Japan (the "Applicant"). The application was published for oppositions on October 15, 2023, and it was registered by office on January 22, 2024 without any oppositions.
The application was filed in English (German was selected as the second language).